StoryRegulatory

Wisconsin federal judge dismisses Onego Bio's patent lawsuit against The Every Company

Onego BioBioalbumen

The US District Court for the Western District of Wisconsin dismissed, for lack of personal jurisdiction, Onego Bio's suit seeking to invalidate a foundational Every Company ovalbumin patent and alleging fraud. An identical suit in Delaware, where both companies are incorporated, is still pending.

  • Onego filed the suits in September 2025
  • Onego uses the fungus Trichoderma reesei; Every uses the yeast Komagataella phaffii
Read the original · Press

More on Bioalbumen

Primer